Navigation Links
Wound Management Technologies, Inc. Announces Negotiations to Acquire BioPharma Management Technologies, Inc.

FORT WORTH, Texas, Dec. 11 /PRNewswire-FirstCall/ -- Wound Management Technologies, Inc., (OTC Bulletin Board: WNDM), announced today that it is exploring a potential acquisition of BioPharma Management Technologies, Inc., a company that has recently launched the development of topical pain management products. "While we have been focusing this year on expanding market penetration of our CellerateRx(R) products, we also have been working to expand our current product portfolio. We believe that the science behind BioPharma's product development shows potential and creates market synergies with our current products," says Scott Haire, Wound Management Technologies' CEO. "We believe that BioPharma's products will provide a broad application across several medical specialities. We are not aware of any currently available products in the market that provide the benefits we expect BioPharma's unique formulation to deliver."

BioPharma is developing a topical pain management product targeting the growing pain management market place. "Based on our research, we believe that this product will provide a broad application across several medical specialities while supplying a good safety profile, expanded dosing range and flexibility, and should create and maintain a moist environment conducive to drug absorption and reduction of irritation at the application site. All year we have focused on Cellerate as a one-of-a-kind product and adding an additional company and product mix should make us a leader in the wound industry and related healthcare markets," states Scott Haire, CEO of Wound Management Technologies. "Also this should significantly increase our revenues in 2010 in all areas of wound care."

CellerateRx(R) is exclusively distributed by Wound Care Innovations, a subsidiary of Wound Management Technologies. It is a one-of-a-kind, patented, advanced wound care collagen product and is FDA cleared for acute and chronic wounds which include but are not limited to: diabetic ulcers, pressure ulcers stage I-IV, venous stasis ulcers, ulcers due to arterial insufficiency, surgical wounds, traumatic wounds, superficial wounds, and 1st and 2nd degree burns. "In 2008, the company has focused on providing additional evidence-based data and has been published in two major wound care publications as well as had a featured speaker at a major wound care conference. Our efforts in 2008 serve to boost customer confidence and will contribute to market success in 2009," states Cathy Bradshaw, President of Wound Care Innovations. "Adding BioPharma's future product mix has the potential to make us a leader in wound care and other medical management areas."

About Wound Management Technologies, Inc.:

Wound Management Technologies, Inc. (WNDM), with its corporate headquarters in Fort Worth, Texas, markets and distributes wound care products to the healthcare market under patented technology licensed to the Company. The Company is positioned and seeks to be a leading provider of wound care products. For more information on the Company please visit the Company's Website at .

"Safe Harbor" Statement: Under The Private Securities Litigation Reform Act of 1995: The statements in the press release that relate to the company's expectations with regard to the future impact on the company's results from new products in development are "forward-looking statements," within the meaning of the Private Securities Litigation Reform Act of 1995. Since this information may contain statements that involve risk and uncertainties and are subject to change at any time, the company's actual results may differ materially from expected results. This document may contain forward-looking statements concerning the Company's operations, current and future performance and financial condition. These items involve risks and uncertainties such as product demand, market and customer acceptance, the effect of economic conditions, competition, pricing, the ability to consummate and integrate acquisitions, and other risks and uncertainties detailed in the Company's SEC filings. The Company undertakes no obligation to revise any of these statements to reflect the future circumstances or the occurrence of unanticipated events.

    Product Information                        Shareholder Relations
    Cathy Bradshaw                             Lucy Singleton
    President                                  Corporate Secretary
    954-315-9242                               817-820-7080

SOURCE Wound Management Technologies, Inc.
Copyright©2008 PR Newswire.
All rights reserved

Related medicine news :

1. Life-Saving News for Battlefield Soldiers & Wounded Civilians
2. LifeNet Health Establishes The Skin & Wound Allograft Institute
3. Operation Mend Offers New Hope for Wounded Warriors
4. PEAK Surgical Announces Positive Surgical Incision Wound Healing Results With the PEAK PlasmaBlade(TM)
5. Remarks by President Bush, Senator Bob Dole and Secretary Donna Shalala on Commission on Care for Americas Returning Wounded Warriors Report Implementation
6. Patients should ask surgeons about using honey to heal wounds
7. The USO and Help Wounded Troops Stay Connected to Their Families
8. Trends in Treatment of Americas Wounded Warriors
9. Report Release: Trends in Treatment of Americas Wounded Warriors
10. Innocoll Receives Intends to Grant Notices from the European Patent Office for Two European Patent Applications Related to Novel Wound Healing, Biosurgery and Drug Delivery Applications of its CollaRx(R) Technology
11. Randy Travis Participates in American Red Cross Holiday Card Program to Wounded Service Members
Post Your Comments:
(Date:12/1/2015)... ... December 01, 2015 , ... It’s official: Tattoo taboo is a ... number even greater among Millennials (a whopping one in three aged 18 to 25 ... who are dissatisfied with their ink. In fact, RealSelf , the world’s largest ...
(Date:12/1/2015)... Illinois (PRWEB) , ... December 01, 2015 , ... ... and share medical images have been lifted as IMAGE Information Systems launches MED-TAB™ ... Society of North America Annual Meeting from November 29 to December 4, 2015. ...
(Date:12/1/2015)... ... December 01, 2015 , ... ... the United States. Podiatrists are well aware that psychology-based patient non-compliance (disobedience of ... often catastrophic contributors to diseases of the diabetic foot. The American Board ...
(Date:12/1/2015)... ... December 01, 2015 , ... The ... adjunctive imaging is the focus of numerous abstracts accepted for presentation here, at ... 2015. Nine abstracts highlight the use of Volpara Solutions’ quantitative breast imaging ...
(Date:12/1/2015)... ... December 01, 2015 , ... ... must mark the film for accurate interpretation by the radiologist. The marking utensils ... inventor from Sacramento, Calif., has found a way to alleviate this problem. , ...
Breaking Medicine News(10 mins):
(Date:12/1/2015)... , Dec. 01, 2015 ... announced the addition of the ... Campylobacter, Cryptosporidium, E. Coli, Enterovirus, Rhinovirus, ... report to their offering. --> ... addition of the "2016 Europe ...
(Date:12/1/2015)... ) has ... and Disposables Market by product, by Animal - ... offering. --> ) has announced ... Disposables Market by product, by Animal - Global ... --> Research and Markets ( ...
(Date:12/1/2015)... , Dec. 1, 2015 Relmada Therapeutics, Inc. (OTCQB: ... of chronic pain, announced today that the company will present ... held December 1-3 at the Luxe Sunset Boulevard Hotel in ... , CEO of Relmada Therapeutics, will present on Thursday, December ... . Please register at least 10 minutes ...
Breaking Medicine Technology: